CLNN - Clene Inc.
5.355
0.055 1.027%
Share volume: 41,126
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$5.30
0.06
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-13-2024 | 03-24-2025 | 05-07-2025 | 11-13-2025 | |
| Assets | |||||||
| Total Assets | 45.069 M | 40.330 M | 31.569 M | 27.337 M | 25.314 M | 22.311 M | |
| Current Assets | 32.111 M | 27.910 M | 19.698 M | 16.157 M | 14.671 M | 12.673 M | |
| Inventories | 37.000 K | 37.000 K | 128.000 K | 68.000 K | 38.000 K | 61.000 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 6.178 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 21.732 M | 21.682 M | 14.645 M | 12.155 M | 9.832 M | 7.925 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 8.854 M | 8.442 M | 8.037 M | 7.479 M | 7.075 M | 6.355 M | |
| Other Assets | 4.104 M | 3.978 M | 3.834 M | 3.701 M | 3.568 M | 3.283 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 45.069 M | 40.330 M | 31.569 M | 27.337 M | 25.314 M | 22.311 M | |
| Total liabilities | 40.805 M | 40.834 M | 35.694 M | 36.194 M | 30.287 M | 34.668 M | |
| Total current liabilities | 26.185 M | 28.069 M | 23.828 M | 10.291 M | 10.764 M | 8.306 M | |
| Accounts Payable | 1.645 M | 1.066 M | 1.678 M | 1.240 M | 1.413 M | 1.369 M | |
| Other liabilities | 2.815 M | 5.752 M | 592.000 K | 10.477 M | 2.688 M | 7.093 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 7.085 M | 7.013 M | 6.939 M | 15.426 M | 12.913 M | 15.785 M | |
| Other liabilities | 2.815 M | 5.752 M | 592.000 K | 10.477 M | 2.688 M | 7.093 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.264 M | -504.000 K | -4.125 M | -8.857 M | -4.973 M | -12.357 M | |
| Common stock | 257.927 M | 259.914 M | 264.226 M | 273.195 M | 277.815 M | 286.563 M | |
| Retained earnings | -253.803 M | -260.588 M | -268.574 M | -282.123 M | -282.874 M | -299.070 M |